This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Strongbridge Dublin Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Fred Cohen: Innovator in Endocrine Treatment
Introduction
Fred Cohen is a notable inventor based in Washington Crossing, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of endocrine disorders. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Fred Cohen holds a patent for Levoketoconazole, which is used for the treatment of congenital adrenal hyperplasia and primary aldosteronism. The patent discloses methods for treating these conditions by administering a therapeutically effective amount of the 2S,4R ketoconazole enantiomer, which is substantially free of the 2R,4S ketoconazole enantiomer. Additionally, the patent includes compositions that utilize this enantiomer for treating diseases associated with congenital adrenal hyperplasia or primary aldosteronism.
Career Highlights
Fred Cohen is associated with Strongbridge Dublin Limited, where he continues to contribute to advancements in medical treatments. His work focuses on developing therapies that improve patient outcomes in endocrine disorders. His dedication to innovation in this field has made a significant impact on healthcare.
Conclusion
Fred Cohen's contributions to the medical field through his patent for Levoketoconazole exemplify the importance of innovation in treating complex health conditions. His work continues to influence the landscape of endocrine treatment, showcasing the vital role of inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile